EBS Competitors & Alternatives
Compare Emergent Biosolutions, Inc. with similar stocks in the same industry
PHARMACEUTICAL PREPARATIONS
EBS
Main Stock$8.38
Tradestie Score
56
Market Cap
$490.30M
P/E Ratio
8.9
Revenue Growth
-0.2%
Analyst Upside
+43.2%
Top Competitors
553 stocks in PHARMACEUTICAL PREPARATIONS| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$954.52
|
$739.95B | 40.0 | 58 | Compare |
|
JNJ
Johnson & Johnson
|
$244.12
|
$448.07B | 22.2 | 64 | Compare |
|
ABBV
ABBVIE INC.
|
$214.98
|
$431.71B | 91.8 | 64 | Compare |
|
NVO
Novo-Nordisk A/S
|
$36.48
|
$262.92B | 10.4 | 55 | Compare |
|
AZN
AstraZeneca PLC
|
$200.73
|
$261.56B | 30.1 | 60 | Compare |
|
NVS
Novartis AG
|
$155.08
|
$254.99B | 21.4 | 61 | Compare |
|
ABT
Abbott Laboratories
|
$102.38
|
$232.30B | 27.6 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$120.84
|
$225.13B | 16.2 | 59 | Compare |
|
PFE
Pfizer Inc.
|
$28.55
|
$154.70B | 20.6 | 69 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.73
|
$121.27B | 20.8 | 63 | Compare |
More EBS Analysis
Data updated: Apr 02, 2026 | Industry: PHARMACEUTICAL PREPARATIONS (SIC 2834)
553 stocks in this industry